|
1 Indications And Usage Fingolimod Capsules Are Indicated For The Treatment Of Relapsing Forms Of Multiple Sclerosis (ms), To Include Clinically Isolated Syndrome, Relapsing-Remitting Disease, And Active Secondary Progressive Disease, In Patients 18 Years Of Age And Older. Pediatric Use Information Is Approved For Novartis Pharmaceuticals Corporation’s Gilenya (fingolimod) Capsules. However, Due To Novartis Pharmaceuticals Corporation's Marketing Exclusivity Rights, This Drug Product Is Not Labeled With That Pediatric Information. Fingolimod Is A Sphingosine 1-Phosphate Receptor Modulator Indicated For The Treatment Of Relapsing Forms Of Multiple Sclerosis (ms), To Include Clinically Isolated Syndrome, Relapsing-Remitting Disease, And Active Secondary Progressive Disease, In Patients 18 Years Of Age And Older. (1)
|